{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:37:26Z","timestamp":1759963046497,"version":"3.44.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.clinbiochem.2014.02.010","type":"journal-article","created":{"date-parts":[[2014,2,18]],"date-time":"2014-02-18T20:15:34Z","timestamp":1392754534000},"page":"485-488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Comparison of anti-CCP autoantibodies measurement by ELISA and a bead-based assay in a large patient cohort"],"prefix":"10.1016","volume":"47","author":[{"given":"Raya","family":"Harich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christelle","family":"Roger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorna","family":"Garnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Bienvenu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Fabien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2014.02.010_bb0005","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/ard.62.9.870","article-title":"Clinical utility of the anti-CCP assay in patients with rheumatic diseases","volume":"62","author":"Lee","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinbiochem.2014.02.010_bb0010","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/ard.2003.008623","article-title":"Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases","volume":"63","author":"Dubucquoi","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinbiochem.2014.02.010_bb0015","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinbiochem.2014.02.010_bb0020","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3899\/jrheum.080656","article-title":"Comparative performance analysis of 4 different anti-citrullinated protein assays in the diagnosis of rheumatoid arthritis","volume":"36","author":"Mutlu","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinbiochem.2014.02.010_bb0025","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/ar2903","article-title":"The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis","volume":"12","author":"Pruijn","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clinbiochem.2014.02.010_bb0030","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1373\/clinchem.2006.078063","article-title":"Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein\/peptide antibodies in the diagnosis of rheumatoid arthritis","volume":"53","author":"Coenen","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinbiochem.2014.02.010_bb0035","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinbiochem.2014.02.010_bb0040","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.clinbiochem.2014.02.010_bb0045","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/ard.2003.019794","article-title":"Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjogren's syndrome","volume":"64","author":"Gottenberg","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinbiochem.2014.02.010_bb0050","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/ard.2006.051391","article-title":"Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review","volume":"65","author":"Avouac","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinbiochem.2014.02.010_bb0055","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.lpm.2008.06.020","article-title":"New autoantibodies in rheumatoid arthritis: anti-citrullinated protein or peptide autoantibodies and the others","volume":"37","author":"Fabien","year":"2008","journal-title":"Presse Med"},{"key":"10.1016\/j.clinbiochem.2014.02.010_bb0060","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12016-008-8073-2","article-title":"Prevalence of autoantibodies to cyclic citrullinated peptide in patients with rheumatic diseases other than rheumatoid arthritis: a French multicenter study","volume":"34","author":"Fabien","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.clinbiochem.2014.02.010_bb0065","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s10067-007-0558-5","article-title":"Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis","volume":"26","author":"Kudo-Tanaka","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clinbiochem.2014.02.010_bb0070","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/ard.2005.044354","article-title":"EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"66","author":"Combe","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinbiochem.2014.02.010_bb0075","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinbiochem.2014.02.010_bb0080","first-page":"231","article-title":"Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis","volume":"32","author":"Raza","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinbiochem.2014.02.010_bb0085","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/art.20044","article-title":"Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study","volume":"50","author":"van Gaalen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinbiochem.2014.02.010_bb0090","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.autrev.2005.02.001","article-title":"Additional diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis","volume":"4","author":"Vallbracht","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clinbiochem.2014.02.010_bb0095","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-146-11-200706050-00008","article-title":"Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis","volume":"146","author":"Nishimura","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinbiochem.2014.02.010_bb0100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/ard.2004.023523","article-title":"Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis","volume":"64","author":"De Rycke","year":"2005","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991201400071X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991201400071X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:44:51Z","timestamp":1757864691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000991201400071X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S000991201400071X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.02.010","relation":{},"ISSN":["0009-9120"],"issn-type":[{"type":"print","value":"0009-9120"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of anti-CCP autoantibodies measurement by ELISA and a bead-based assay in a large patient cohort","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}